Pfizer (PFE)
Pfizer Historical Price Data
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 30, 2012 | 22.07 | 22.22 | 22.01 | 22.04 | 21542298 |
| May 29, 2012 | 22.18 | 22.42 | 22.13 | 22.18 | 30746049 |
| May 25, 2012 | 22.15 | 22.33 | 21.96 | 22.13 | 19417489 |
| May 24, 2012 | 22.15 | 22.17 | 21.92 | 22.14 | 26166854 |
| May 23, 2012 | 22.38 | 22.42 | 21.91 | 22.09 | 52061938 |
| May 22, 2012 | 22.48 | 22.68 | 22.22 | 22.37 | 35308704 |
| May 21, 2012 | 22.55 | 22.63 | 22.47 | 22.54 | 36869356 |
| May 18, 2012 | 22.61 | 22.64 | 22.34 | 22.57 | 41817245 |
| May 17, 2012 | 22.62 | 22.80 | 22.53 | 22.56 | 38403330 |
| May 16, 2012 | 22.32 | 22.68 | 22.30 | 22.64 | 39474909 |
| May 15, 2012 | 22.56 | 22.60 | 22.25 | 22.30 | 37870025 |
| May 14, 2012 | 22.46 | 22.76 | 22.42 | 22.58 | 31017191 |
| May 11, 2012 | 22.74 | 22.97 | 22.63 | 22.65 | 33724534 |
| May 10, 2012 | 22.70 | 22.99 | 22.62 | 22.83 | 53334390 |
| May 9, 2012 | 22.07 | 22.79 | 21.95 | 22.45 | 74400248 |
| May 8, 2012 | 22.36 | 22.52 | 22.27 | 22.42 | 30952670 |
| May 7, 2012 | 22.24 | 22.57 | 22.24 | 22.45 | 34785916 |
| May 4, 2012 | 22.52 | 22.58 | 22.28 | 22.38 | 35575619 |
| May 3, 2012 | 22.67 | 22.70 | 22.51 | 22.60 | 25103722 |
| May 2, 2012 | 22.69 | 22.98 | 22.58 | 22.66 | 33191845 |
| May 1, 2012 | 22.63 | 22.99 | 22.55 | 22.78 | 43160716 |
| April 30, 2012 | 23.02 | 23.10 | 22.80 | 22.90 | 74907665 |
| April 27, 2012 | 23.14 | 23.30 | 22.98 | 23.08 | 87145892 |
| April 26, 2012 | 22.87 | 23.11 | 22.82 | 23.06 | 110843955 |
| April 25, 2012 | 22.77 | 22.98 | 22.74 | 22.88 | 30693792 |
| April 24, 2012 | 22.39 | 22.80 | 22.35 | 22.63 | 35547021 |
| April 23, 2012 | 22.56 | 22.53 | 22.32 | 22.38 | 24578048 |
| April 20, 2012 | 22.31 | 22.73 | 22.28 | 22.56 | 37825771 |
| April 19, 2012 | 22.53 | 22.58 | 22.20 | 22.34 | 31451007 |
| April 18, 2012 | 22.22 | 22.60 | 22.16 | 22.45 | 31549074 |
| April 17, 2012 | 22.03 | 22.35 | 21.97 | 22.31 | 29100928 |
| April 16, 2012 | 21.84 | 22.06 | 21.77 | 21.98 | 38005360 |
| April 13, 2012 | 21.82 | 22.00 | 21.81 | 21.85 | 36929930 |
| April 12, 2012 | 22.05 | 22.05 | 21.86 | 21.92 | 40459969 |
| April 11, 2012 | 22.07 | 22.16 | 21.92 | 21.95 | 37585078 |
| April 10, 2012 | 22.03 | 22.56 | 21.95 | 21.98 | 48119508 |
| April 9, 2012 | 22.07 | 22.23 | 22.01 | 22.05 | 22516394 |
| April 5, 2012 | 22.27 | 22.36 | 22.22 | 22.34 | 22058812 |
| April 4, 2012 | 22.42 | 22.45 | 22.25 | 22.38 | 30366590 |
| April 3, 2012 | 22.55 | 22.66 | 22.35 | 22.54 | 37637765 |
| April 2, 2012 | 22.54 | 22.73 | 22.49 | 22.59 | 34755344 |
| March 30, 2012 | 22.45 | 22.76 | 22.42 | 22.64 | 33996939 |
| March 29, 2012 | 22.26 | 22.45 | 22.18 | 22.42 | 33356620 |
| March 28, 2012 | 22.56 | 22.59 | 22.21 | 22.41 | 32971226 |
| March 27, 2012 | 22.29 | 22.80 | 22.26 | 22.50 | 61259204 |
| March 26, 2012 | 21.95 | 22.26 | 21.95 | 22.16 | 33341412 |
| March 23, 2012 | 21.78 | 21.97 | 21.71 | 21.82 | 23261749 |
| March 22, 2012 | 21.73 | 21.86 | 21.70 | 21.73 | 21099492 |
| March 21, 2012 | 21.83 | 21.98 | 21.76 | 21.77 | 26666180 |
| March 20, 2012 | 21.76 | 22.00 | 21.76 | 21.80 | 24163808 |
PFE News
$AMRN I would be surprised if $PFE isn't having backchannel talks pre-889.$AMRN is a perfect takeout...very few employees and cinch approval
about 7 hours ago by InTheBarn
about 7 hours ago by InTheBarn
Drug Stocks In The Spotlight At ASCO Conference. $JNJ $CELG $ONXX $RHHBY $PFE http://stks.co/42e8
about 17 hours ago by abubnic
about 17 hours ago by abubnic
@SciGuy $DRRX I don't believe so; the fortunes of DURECT are tied to $PFE and Remoxy
about 20 hours ago by SlownSteady
about 20 hours ago by SlownSteady
@SCarolinaguy $DRRX licensed the drug to $PTIE; $PTIE licensed it to King and $PFE bought King; I think people might forget about $DRRX
about 21 hours ago by SlownSteady
about 21 hours ago by SlownSteady
@SlownSteady Sounds encouraging with $PFE supporting. What is the relationship? Surely their support would lead to approval
about 21 hours ago by SCarolinaguy
about 21 hours ago by SCarolinaguy
@SCarolinaguy $DRRX $PFE plans to resubmit the NDA. The company has other products; a recent filed trial triggered share price punishment
about 21 hours ago by SlownSteady
about 21 hours ago by SlownSteady
@SCarolinaguy $DRRX Only insiders know. CMC problems are usually resolved. $PFE will have new data and meet with the FDA
about 21 hours ago by SlownSteady
about 21 hours ago by SlownSteady
RT @Glopolon: Does it matter, they are next door to $PFE $AMRN /i live next to a lawyer. odds of being sued increased day they moved in. Hmm
about 4 days ago by ITradeforMe
about 4 days ago by ITradeforMe
RT @Glopolon $AMRN $PFE 'I wanna get close to you' Rose Royce http://stks.co/404L <Hmmmmmmmm!?$$$
about 4 days ago by Bleedblue
about 4 days ago by Bleedblue
$AMRN $PFE 'I wanna get close to you' Rose Royce http://stks.co/404H
about 4 days ago by Glopolon
about 4 days ago by Glopolon
@SomeGuy900 @christy155 $DRXX If $PFE gets a class 2 resubmission, they'll know in Q2/Q3 of next year; class one they'll know in Q1/Q2 '13
about 5 days ago by SlownSteady
about 5 days ago by SlownSteady
@SomeGuy900 @christy155 $DRXX The $PFE discussions with the FDA should be in Q3; I imagine they will resubmit in early 2013
about 5 days ago by SlownSteady
about 5 days ago by SlownSteady
@SomeGuy900 @christy155 The last comment from $DRRX management was that $PFE was getting ready to talk to the FDA about some more studies
about 5 days ago by SlownSteady
about 5 days ago by SlownSteady
@SomeGuy900 @christy155 $DRRX I have no idea what's going on. It's gone up 20 cents since I bought in. Maybe $PFE will talk with the FDA
about 5 days ago by SlownSteady
about 5 days ago by SlownSteady
Pfizer (PFE) Promotes Olivier Brandicourt to GM of Emerging Markets, Established Products Units
May 23, 7:31AM Street Insider
May 23, 7:31AM Street Insider
Pfizer (PF) Updates on Effect of Lyrica on Pain in Fibromyalgia Patients
May 18, 8:02AM Street Insider
May 18, 8:02AM Street Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| PFE | 21.87 | -0.17 | -0.77% | 166.12B |
| PETM | 64.47 | +0.02 | +0.03% | 7.082B |
| PETD | 24.80 | +0.06 | +0.22% | 584.84M |
| PERY | 18.82 | -0.07 | -0.37% | 296.95M |
| PERI | 3.86 | -0.19 | -4.69% | 40.18M |
| PERF | 7.80 | -0.01 | -0.13% | 70.06M |
| PER | 19.93 | -0.07 | -0.35% | 787.60M |
| PEP | 67.99 | -0.23 | -0.34% | 108.30B |
| PEOP | 16.08 | +0.33 | +2.10% | |
| PEO | 23.01 | -0.18 | -0.78% |